Pravin Chaturvedi
Napo Pharmaceuticals, Inc. · Napo Pharmaceuticals
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Pravin Chaturvedi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:17 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT06721871 · Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)Napo Pharmaceuticals, Inc. · active not recruiting · Microvillus Inclusion Disease, Congenital Disorders, Rare Diseases · study chair
- Ph3NCT04538625 · Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer TherapyNapo Pharmaceuticals, Inc. · completed · Cancer Therapy-Related Diarrhea, Chemotherapy-related Diarrhea, Adult Solid Tumor · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:17 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Process Chemistry of Largazole, a Marine HDAC Inhibitor with Anticancer ActivityR43CA195895 · NCI · OCEANYX PHARMACEUTICALS, INC. · fiscal years 2015 · $291,335 awarded in 2015Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:17 UTC. The ranking covers the 200 most relevant of 32 PubMed records, and a shared surname and initials can bring in a namesake. All 32 on PubMed
- Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.N Engl J Med · 2015929 citationsRCR 36.5
- Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.J Clin Oncol · 2018252 citationsRCR 11.3
- Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial.Radiother Oncol · 2012239 citationsRCR 8.7
- Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans.J Pharmacol Exp Ther · 2013190 citationsRCR 5.1
- 124 citationsRCR 3.4
- 94 citationsRCR 3.8
- Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin.J Clin Oncol · 200181 citationsRCR 2.1
- Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.J Clin Oncol · 202375 citationsRCR 8.1
- 67 citationsRCR 5.4
- 49 citationsRCR 1.9